Evaluation of the association between St. John's wort and elevated thyroid-stimulating hormone

Pharmacotherapy. 2001 Dec;21(12):1574-8. doi: 10.1592/phco.21.20.1574.34483.

Abstract

Study objective: To evaluate whether St. John's wort is associated with an elevation in thyroid-stimulating hormone (TSH) levels.

Design: Retrospective case-control study

Setting: Hamilton, Ontario; September 1998-May 1999.

Subjects: Thirty-seven subjects with elevated TSH levels and 37 age- (+/- 6 yrs) and gender-matched subjects with normal TSH levels who resided in the same region.

Measurements and main results: Exposure to St. John's wort during the 3-6 months before TSH measurement was assessed through a telephone interview. A total of 4 of 37 subjects with elevated TSH levels and 2 of 37 subjects with normal TSH levels had taken St. John's wort in that time period. The odds ratio for elevated TSH levels associated with taking St. John's wort was 2.12 (95% confidence interval [CI] 0.36-12.36).

Conclusion: This study suggests a probable association between St. John's wort and elevated TSH levels. However, because of the wide CIs surrounding the point estimate (which crosses unity), further investigation, including a large, prospective cohort study, is warranted.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antidepressive Agents / adverse effects*
  • Case-Control Studies
  • Female
  • Humans
  • Hypericum / adverse effects*
  • Hypothyroidism / chemically induced
  • Male
  • Middle Aged
  • Retrospective Studies
  • Thyrotropin / blood*

Substances

  • Antidepressive Agents
  • Thyrotropin